CORTEXA
← Browse
openalexFrontiers in Oncology2026-07-23Cited by 0

A case report of uterine adenosarcoma with sarcomatous overgrowth and pulmonary metastasis

Xiaotian Qi, Q Q Wang, Jiutao Zheng, Nana Guo, Zhichun Zhang, Hongli Li, Min Dai

Background Uterine adenosarcoma is a rare malignant tumor characterized by a biphasic pattern consisting of benign epithelial components and sarcomatous stroma. The subtype with sarcomatous overgrowth is more aggressive and poses significant challenges in clinical diagnosis and management. We report the case of a 56-year-old postmenopausal woman who presented with left inguinal stabbing pain for half a month. Transvaginal ultrasonography revealed multiple nodules in the myometrium and a cystic-solid mass in the left adnexal region (65 mm × 46 mm). The patient was initially admitted with a presumptive diagnosis of “teratoma” and “uterine fibroids.” Postoperative histopathological examination of the total hysterectomy with bilateral salpingo-oophorectomy confirmed uterine adenosarcoma with hemorrhage and focal osseous metaplasia. After eight months of routine postoperative chemotherapy, chest computed tomography (CT) demonstrated pulmonary metastases. Genetic testing of the tumor tissue did not identify any mutations or gene fusions of clinical significance. Conclusion This case highlights the complexity and diagnostic challenges of uterine adenosarcoma in clinicopathological practice. Sarcomatous overgrowth and myometrial invasion are important adverse prognostic factors. No common driver gene mutations were detected in the tumor tissue of this patient, suggesting that tumorigenesis may involve more complex epigenetic regulatory mechanisms, which warrant further investigation.

View free PDFSource page

Related papers

openalexFrontiers in Oncology2026-07-24

Case Report: Long-term survival in extensive-stage small cell lung cancer treated with adebrelimab-based combination therapy

Xia Y, Yuxian Yang, Wanzhong Huang, Yongshun Chen

The integration of immune checkpoint inhibitors into first-line treatment has markedly improved outcomes for extensive-stage small cell lung cancer (ES-SCLC). Adebrelimab, a PD-L1 inhibitor, demonstrated superior overall survival in the phase 3 CAPSTONE-1 trial. We present a deta…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells

R K Watanabe, Mami Chosei, Haruna Arai, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika

Introduction Neuroendocrine prostate cancer (NEPC) is an aggressive treatment-associated lineage state emerging with potent androgen receptor (AR) pathway inhibition. Although treatment-emergent NEPC is increasingly recognized, the transcriptional consequences of sustained AR sup…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Construction and validation of a machine learning model for predicting anastomotic leak following radical esophagectomy for esophageal cancer

Yueying Yang, Kayishaer Ainiwaer, Yunfei Gao, An Li, Abulajiang Kamili, Dongbo Luo

Background Early identification of patients at high risk of anastomotic leak (AL) following esophagectomy is essential for improving surgical outcomes. However, reliable preoperative risk stratification remains challenging. This study aimed to predict AL risk in the esophageal ca…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Spontaneous rupture of a clinically recurrent intracranial dermoid cyst: a case report and narrative review

Hongyuan Liu, Hui Zeng, Bufan Yang, Yuzhu Ji, Zongping Li, Liangxue Zhou

Objective To describe the clinical, pathological, and therapeutic features of spontaneous rupture of a recurrent intracranial dermoid cyst (IDC), and to summarize relevant dermoid-specific literature. Methods We report a 38-year-old woman with a clinical history of resection of a…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth

Gaochao Guo, Yan Sun, Rujun Hong, Yalin Lu, Xingjie Chen, Liming Zhao, et al.

Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a member of the serine/threonine kinase family, is an important oncogene in glioblastoma. IKBKE is involved in the progression of multiple tumours in glioblastoma (GBM), including tumour invasion, migration, and…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies

Ashley R Tetens, Jordyn Craig-Schwartz, Tyler Findlay, Michael A. Koldobskiy

The advent of cancer immunotherapy has led to dramatically improved outcomes in several immunogenic adult cancers. Similar successes have been seen in some pediatric cancers, but only in specific settings. A particular challenge has been the application of immunotherapy approache…

View free PDFSource page